Synvisc Injections for Lumbar Facet Joint Pain

Status unconfirmed · Phase 3

Conditions studied: Joint Pain

In brief

The objective of this investigation is to evaluate the safety and efficacy of viscosupplementation in treating symptomatic lumbar facet joint arthropathy. The intended use of the device (Synvisc) is to alleviate pain and improve function in patients with painful lumbar facet joint arthrosis by intra-articular injection into the involved joint.

Key facts

Study ID
NCT00325845
Run by
Sheltering Arms Physical Rehabilitation Hospitals
People needed
15
Starts
2006-05-01
Expected to finish
2008-05-01
Last updated by the study team
2006-09-13

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.